Docusign Inc. $DOCU Shares Purchased by Nippon Life Global Investors Americas Inc.

Key Points

• Nippon Life Global Investors Americas Inc. increased its stake in Docusign Inc. by 84.4% in the first quarter, owning approximately $14.2 million worth of shares.
• Recent analyst reports have resulted in mixed price targets for Docusign; JPMorgan lowered its target to $77.00, while Wells Fargo raised theirs to $80.00.
• Docusign reported a Q2 earnings per share of $0.92, surpassing estimates, with revenue rising 8.8% year-over-year.

Nippon Life Global Investors Americas Inc. grew its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 84.4% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 174,160 shares of the company's stock after acquiring an additional 79,720 shares during the period. Nippon Life Global Investors Americas Inc. owned about 0.09% of Docusign worth $14,177,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Palogic Value Management L.P. boosted its holdings in shares of Docusign by 2.2% in the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company's stock valued at $443,000 after acquiring an additional 117 shares in the last quarter. Wealthspire Advisors LLC lifted its stake in shares of Docusign by 1.9% in the first quarter. Wealthspire Advisors LLC now owns 6,579 shares of the company's stock valued at $536,000 after purchasing an additional 122 shares during the period. Foundry Partners LLC boosted its holdings in Docusign by 1.5% during the first quarter. Foundry Partners LLC now owns 8,491 shares of the company's stock worth $691,000 after buying an additional 125 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Docusign by 27.5% during the first quarter. Bessemer Group Inc. now owns 602 shares of the company's stock worth $49,000 after buying an additional 130 shares in the last quarter. Finally, Brooklyn Investment Group boosted its holdings in Docusign by 24.9% during the first quarter. Brooklyn Investment Group now owns 702 shares of the company's stock worth $57,000 after buying an additional 140 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Docusign Price Performance

Shares of NASDAQ DOCU traded down $1.58 on Wednesday, hitting $78.22. The company's stock had a trading volume of 2,163,099 shares, compared to its average volume of 2,662,367. Docusign Inc. has a 12-month low of $54.31 and a 12-month high of $107.86. The company has a market capitalization of $15.80 billion, a price-to-earnings ratio of 58.90, a price-to-earnings-growth ratio of 4.72 and a beta of 1.02. The stock has a 50 day moving average of $75.66 and a 200-day moving average of $79.29.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same quarter in the prior year, the firm earned $0.97 earnings per share. The company's revenue for the quarter was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Sell-side analysts expect that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has authorized a share repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Wedbush decreased their price objective on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, June 12th. Wall Street Zen downgraded shares of Docusign from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Evercore ISI boosted their price objective on shares of Docusign from $90.00 to $92.00 and gave the stock an "in-line" rating in a report on Friday, September 5th. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a report on Friday, September 5th. Finally, Piper Sandler boosted their price objective on shares of Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a report on Friday, September 5th. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to MarketBeat, Docusign currently has a consensus rating of "Hold" and a consensus price target of $94.14.

Insider Activity

In other news, insider Robert Chatwani sold 22,875 shares of the business's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the transaction, the insider owned 72,126 shares of the company's stock, valued at $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the business's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the completion of the transaction, the chief financial officer directly owned 110,723 shares of the company's stock, valued at approximately $8,282,080.40. This represents a 12.03% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 78,552 shares of company stock worth $5,983,631. Corporate insiders own 1.66% of the company's stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.